Interestingly, miR-141-3p upregulation and MAPK8 (JNK1) signaling downregulation have been reported in platinum-based chemotherapy in ovarian cancer cell lines (Ying et al., 2015; Li et al., 2018). This evidence concerns the gene MAPK8 and ovarian carcinoma.